Discover
CLOV
Clover Health Investments, Corp.
4.41
33 x 4.41
28 x 4.42
bid
ask
-
0.16
3.47%
01:30 PM
timesize
| Ytd | 87.72% | |
| 1y | 78.60% |
4.34
day range
4.59
1.58
52 week range
5.59
| Open | 4.55 | Prev Close | 4.57 | Low | 4.34 | High | 4.59 | Mkt Cap | 2.29B |
| Vol | 2.16M | Avg Vol | 7.31M | EPS | 0.04 | P/E | 103.54 | Forward P/E | 31.73 |
| Beta | 2.47 | Short Ratio | 4.12 | Inst. Own | 30.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.61 | 200-d Avg | 3.03 | 1yr Est | 5.17 |
| Income Statement | |||
| Total Revenue | 743.17M | ||
| Revenues (USD) | 743.17M | ||
| Cost of Revenue | 590.17M | ||
| Gross Profit | 153.00M | ||
| Operating Expenses | 125.00M | ||
| Selling, General and Administrative Expense | 124.44M | ||
| Operating Income | 28.00M | ||
| Net Income | 28.00M | ||
| Net Income Common Stock | 28.00M | ||
| Net Income Common Stock (USD) | 28.00M | ||
| Consolidated Income | 28.00M | ||
| Earnings per Basic Share | 0.05 | ||
| Earnings per Basic Share (USD) | 0.05 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 28.00M | ||
| Earning Before Interest & Taxes (USD) | 28.00M | ||
| Weighted Average Shares | 524.19M | ||
| Weighted Average Shares Diluted | 545.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 198.84M | ||
| Cash and Equivalents (USD) | 198.84M | ||
| Investments | 244.18M | ||
| Investments Current | 44.26M | ||
| Investments Non-Current | 199.91M | ||
| Trade and Non-Trade Receivables | 73.12M | ||
| Current Assets | 485.45M | ||
| Property, Plant & Equipment Net | 7.23M | ||
| Total Assets | 720.33M | ||
| Current Liabilities | 323.33M | ||
| Total Liabilities | 344.07M | ||
| Accumulated Retained Earnings (Deficit) | -2.23B | ||
| Accumulated Other Comprehensive Income | -1.55M | ||
| Shareholders Equity | 376.26M | ||
| Shareholders Equity (USD) | 376.26M | ||
| Assets Non-Current | 234.88M | ||
| Goodwill and Intangible Assets | 2.99M | ||
| Liabilities Non-Current | 20.74M | ||
| Trade and Non-Trade Payables | 286.30M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 564.00K | ||
| Net Cash Flow from Financing | 416.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 25.57M | ||
| Capital Expenditure | -682.00K | ||
| Issuance (Purchase) of Equity Shares | 416.00K | ||
| Net Cash Flow from Investing | -32.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 650.00K | ||
| Net Cash Flow from Operations | 25.19M | ||
| Share Based Compensation | 9.08M | ||